- Home » News and Events
NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline
Jul 29, 2020
Catalent will support the development, manufacturing, and clinical supply of Editas Medicine’s portfolio of in vivo CRISPR medicines and engineered cell medicines.
Catalent Biologics’ Executive to Discuss Manufacturing Scale-up During a Pandemic
Jul 22, 2020
Catalent today announced that Mike Riley, Region President, Biologics, North America, will present at the upcoming Disease Prevention & Control Summit, taking place virtually on July 28 – 29, 2020.
Catalent Biologics to Invest $30 Million to Create European Clinical Manufacturing Center of Excellence in Limoges, France
Jul 22, 2020
Catalent today announced that it plans to invest $30 million (€27 million) at its facility in Limoges, France, to create a European center of excellence for clinical biologics formulation development and drug product fill-finish services.
Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab
Jul 16, 2020
Catalent and Humanigen today announced the expansion of their relationship, under which Catalent will provide development, manufacturing and commercialization services for lenzilumab.
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Jun 25, 2020
Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca and prepare for large-scale commercial supply of the COVID-19 vaccine candidate, AZD1222.
Catalent to Discuss Data-Driven Approaches for Small Molecule Drug Development at the Controlled Release Society Annual Meeting
Jun 24, 2020
Catalent today announced that a number of its experts will present at the upcoming Controlled Release Society (CRS) Annual Meeting, which will take place virtually on June 29 – July 2, 2020.
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Jun 15, 2020
Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca and prepare for large-scale commercial supply of the COVID-19 vaccine candidate, AZD1222.
Catalent Partners with Spicona to Develop COVID-19 Vaccine Candidate Using GPEx® Cell Line Development Platform
Jun 10, 2020
Catalent today announced that it has signed an agreement with Spicona, Inc. to develop a virus-like protein (VLP)-based vaccine against COVID-19 at its Madison, Wisconsin facility.
Catalent’s Chair and CEO, John Chiminski, to Speak About R&D Leadership Through the Pandemic During BIO Digital
Jun 4, 2020
Catalent today announced that John Chiminski, Chair and Chief Executive Officer, will join other R&D leaders to present during BIO Digital, which will take place on June 8 – 12, 2020.
World Orphan Drug Congress
Date: August 24 – 26, 2020
BioProcessing Summit 2020 USA
Date: August 24 – 28, 2020
PEGS Boston
Date: August 31- September 4, 2020
BioProcess International
Date: September 21-25, 2020
World Vaccine Congress
Date: September 28 – October 1, 2020
PDA Universe of Pre-Filled Syringes and Injection Devices
Date: October 5-6, 2020
Gene Therapy for Rare Disorders
Date: February 22-25, 2021
ISOBiotech Spring Meeting
Date: March 15-17, 2021
Cell Culture Engineering XVII
Date: April 18-21, 2021
Interphex
Date: April 20-22, 2021